SCHEMBL15326430

SCHEMBL15326430

CC(C)NC(=O)C1OC(C)(C)OC1C

nearest known ligand 0.42

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PGD P52209 1/20 0.33
CHRNB2 P17787 1/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNA4 P43681 1/20 0.32
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15325122 1.00 MAPK1 (0.42) MAPK1NPSR1PGDCHRNB2CHRNB4
SCHEMBL15326452 0.79 MAPK1 (0.42) MAPK1NPSR1PGD
SCHEMBL16639440 0.76 CHRNB2 (0.37) MAPK1CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL16466637 0.76 CHRNB2 (0.37) MAPK1CHRNB2CHRNB4CHRNA3CHRNA7
SCHEMBL16639433 0.76 MAPK1 (0.40) MAPK1NPSR1PGD
SCHEMBL15325113 0.76 MAPK1 (0.40) MAPK1NPSR1PGD
SCHEMBL18658569 0.74 GAA (0.48) MAPK1NPSR1PGD
SCHEMBL15326412 0.71 MAPK1 (0.37) MAPK1NPSR1PGDCHRNB2CHRNB4
SCHEMBL16488404 0.71 MAPK1 (0.37) MAPK1NPSR1PGD
SCHEMBL14527074 0.71 SUCNR1 (0.38) MAPK1NPSR1PGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2837629-B1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE ASYMCHEM LABORATORIES (TIANJIN) CO LTD (CN) 2017-03-22 EP disclosed
EP-2837629-B1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE ASYMCHEM LABORATORIES (TIANJIN) CO LTD (CN) 2017-03-22 EP disclosed
US-9371326-B2 Method for synthesizing sapropterin dihydrochloride ASYMCHEM LABORATORIES (TIANJIN) CO., LTD (CN) 2016-06-21 US disclosed
US-9371326-B2 Method for synthesizing sapropterin dihydrochloride ASYMCHEM LABORATORIES (TIANJIN) CO., LTD (CN) 2016-06-21 US disclosed
US-9371326-B2 Method for synthesizing sapropterin dihydrochloride ASYMCHEM LABORATORIES (TIANJIN) CO., LTD (CN) 2016-06-21 US disclosed
US-20150119573-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE TIANJIN ASYMCHEM PHARMACEUTICAL CO., LTD (CN) 2015-04-30 US disclosed
US-20150119573-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE TIANJIN ASYMCHEM PHARMACEUTICAL CO., LTD (CN) 2015-04-30 US disclosed
US-20150119573-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE TIANJIN ASYMCHEM PHARMACEUTICAL CO., LTD (CN) 2015-04-30 US disclosed
EP-2837629-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE Asymchem Laboratories (Tianjin) Co., Ltd (CN) 2015-02-18 EP disclosed
EP-2837629-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE Asymchem Laboratories (Tianjin) Co., Ltd (CN) 2015-02-18 EP disclosed
WO-2013152608-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE 凯莱英医药集团(天津)股份有限公司 (CN) 2013-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119573-A1 METHOD FOR SYNTHESIZING SAPROPTERIN DIHYDROCHLORIDE DHCR7, CYP51A1, HMGCR MAPK1 2845/4885NPSR1 328/4885PGD 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.